Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

  • Diagnosed with HIV at a low CD4 count

    NAM's factsheet on being diagnosed with HIV when already at a low CD4 cell count...

    From: Factsheets

    Information level Level 2
  • Tuberculosis

    Tuberculosis (TB) is an infection that usually affects the lungs.It can be very serious, particularly for people with HIV who have a low CD4 count.TB can be...

    From: Factsheets

    Information level Level 2
  • TB and HIV

    If HIV has weakened your immune system, you are more vulnerable to infection with tuberculosis (TB). TB is an infection caused by bacteria. It is...

    From: The basics

    Information level Level 1
  • Treatment for TB and HIV

    If tuberculosis (TB) is making you ill and you also have HIV, then you usually need to take treatment for both TB and HIV.You can...

    From: The basics

    Information level Level 1

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • Underfunding ‘nightmare’ hampers the global TB battle

    There is a “nightmare of underfunding” for tuberculosis (TB), described by experts as “the greatest infectious disease killer on the planet”.

    31 October 2016 | Health-e
  • South Africa’s healthcare workers hard hit by TB infections

    Exposure to infectious patients, high HIV rates and a lack of ventilation in facilities are some of the reasons healthcare workers in South Africa have the one of the highest tuberculosis (TB) infection rates in the world.

    27 October 2016 | Health-e
  • 2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time To Lose

    Tuberculosis (TB) killed 1.8 million people in 2015, making it the most deadly infectious disease worldwide, but funding for research into better TB prevention, diagnosis, and treatment dropped by US$53.4 million, according to Treatment Action Group’s 2016 Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose.

    26 October 2016 | Treatment Action Group
  • ‘True Scale’ of India’s Tuberculosis Problem: 2.8 Million New Cases

    Finally coming to terms with the enormity of its tuberculosis problem, India is preparing a radical overhaul and expansion of its national treatment program to fight an affliction that kills more adults worldwide than any other infectious disease.

    17 October 2016 | New York Times
  • WHO report warns global actions and investments to end tuberculosis epidemic are falling far short

    New data published by WHO in its 2016 "Global Tuberculosis Report" show that countries need to move much faster to prevent, detect, and treat the disease if they are to meet global targets.

    14 October 2016 | World Health Organization
  • The Lancet: Migrants screened for active tuberculosis pose negligible risk of spreading infection but can still get disease later

    Tuberculosis incidence in the UK has declined over the past four years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

    13 October 2016 | Eurekalert Medicine & Health
  • Zimbabwe study sees TB go down as HIV treatment coverage goes up

    As the numbers of people accessing HIV treatment went up in Zimbabwe, the numbers of reported tuberculosis cases were cut nearly in half.

    06 October 2016 | Science Speaks
  • New TB report shows continuing decline in cases in England

    New 2015 data shows evidence of positive start to the early implementation of the TB Strategy with cases down by a third since 2011 peak.

    28 September 2016 | Public Health England
  • Professor Stephen Lawn

    Steve Lawn, who made major contributions to the diagnosis and treatment of tuberculosis among populations affected by HIV/AIDS, and to reducing the burden of HIV-associated TB, has died at the age of 50. His pioneering work has resulted in over 250 publications including many influential papers particularly on rapid diagnostic screening for TB, and making important contributions to World Health Organization guidelines.

    28 September 2016 | LSHTM TB Centre
  • UK pledges £1.1bn to global aid fund against Aids, TB and malaria

    Britain will contribute £1.1bn to a global aid fund to help fight Aids, tuberculosis and malaria, but will attach a set of “demanding” performance targets, Priti Patel has announced. The money will fund 40m bed nets to tackle malaria, provide enough antiretroviral therapy for 1.3 million people with HIV and support the treatment of 800,000 people with tuberculosis. A proportion of the investment will be used to leverage £100m from the private sector specifically to tackle malaria.

    20 September 2016 | The Guardian
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.